source
- Amneal to acquire biosimilar maker for $375 million upfrontAmneal Pharmaceuticals announced it will purchase a biosimilar development company, agreeing to pay $375 million in an upfront cash payment. The deal expands Amneal’s portfolio in the growing biosi…
- Sanofi defends Garijo appointment and reaffirms commitment to immunology ahead of new CEOSanofi held its first-quarter earnings call, with CFO François-Xavier Roger fielding questions from the media. During the call he defended the recent appointment of Belén Garijo, formerly of Merck…